Endometrial cancer, types, prognosis, female hormones and antihormones (Q37855938)

24 August 2017

1 reference

title

Endometrial cancer, types, prognosis, female hormones and antihormones (English)

1 reference

24 August 2017

1 reference

L S G Ulrich

1

1 reference

24 August 2017

publication date

22 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

14

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

418-425

1 reference

Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Histopathology of endometrial hyperplasia and endometrial carcinoma: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

The role of transvaginal ultrasound or endometrial biopsy in the evaluation of the menopausal endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

A thin and regular endometrium on ultrasound is very unlikely in patients with endometrial malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

The oncogenic potential of endometrial polyps: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Assessment of the risk on endometrial cancer in hyperplasia, by means of morphological and morphometrical features

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long-term retrospective study from northern Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Postmenopausal hormone replacement therapy: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Low-potency oestrogen and risk of endometrial cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Endometrial safety of ultra-low-dose Vagifem 10 microg in postmenopausal women with vaginal atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Estrogen-progestin replacement therapy and endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Endometrial cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Tibolone and endometrial cancer: a cohort and nested case-control study in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Endometrial effects of tibolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecologically symptomatic and asymptomatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Aromatase inhibitors--a triumph of translational oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Progestin therapy of complex endometrial hyperplasia with and without atypia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

The management of endometrial hyperplasia: an evaluation of current practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Treatment of endometrial hyperplasia without atypia in peri- and postmenopausal women with a levonorgestrel intrauterine device.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Outcome of fertility-preserving treatment in young women with endometrial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Coexisting ovarian malignancy in young women with endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Feasibility of ovarian preservation in patients with early stage endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Hormone replacement therapy after treatment of endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Estrogen replacement in surgical stage I and II endometrial cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Estrogen replacement therapy following treatment for stage I endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

Body Mass and Endometrial Cancer Risk by Hormone Replacement Therapy and Cancer Subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.550974

10.3109/13697137.2010.550974

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference